Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Professor Sherene Loi receives the Frank Fenner Prize for Life Scientist of the Year
For her ground-breaking work in breast cancer, Professor Sherene Loi has received the Frank Fenner…
Low vitamin D status may lead to elevated colorectal cancer risk in black women
A new study from the Slone Epidemiology Center and the Boston University School of Medicine,…
Radiotherapy patients prefer telemedicine to in-person visits
New research in the October 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network assessed patient…
Brain metastases common and difficult to treat in ROS1 lung cancer
- More than 1 in 3 lung cancer patients present at emergency department around the time of diagnosis
- Increase in lifestyle-related cancers over past decade spotlights need for prevention
- Immunotherapy Pembrolizumab Works Better Than Chemotherapy Alone as Initial Treatment for Most Advanced Lung Cancers
New drug halves hearing loss in children following cancer treatment
Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to findings published…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.